RedHawk is engaged in the sales and distribution of medical devices, sales of branded generic pharmaceutical drugs, commercial real estate investment and leasing, sales of point of entry full-body security systems, and specialized financial services.
FREMONT, CA: RedHawk, a diversified holding company primarily engaged in sales and distribution of medical devices, announced that it has completed the re-design of the SANDD Pro, the company's needle incineration unit specifically engineered for use by hospitals, clinics, medical practitioners, retirement homes and in other medical facilities. The company has now started the manufacturing process for the SANDD Pro.
Commenting on the launch of the SANDD Pro, G. Darcy Klug, RedHawk's Chairman of the Board and Chief Financial Officer, said, "The 2020 calendar year has definitely been challenging thus far. This year has demanded patience, resilience, durability, and flexibility. We started the 2020 calendar year with increasing sales of our line of SANDD mini needle incineration devices resulting from increased recognition and acceptance of our line of SANDD mini needle incineration devices by school systems and first responders in Louisiana, Texas, California, Oklahoma, Wyoming, Mississippi, Minnesota, and Nevada.
"In December 2019, a novel strain of coronavirus surfaced in Wuhan, China, and spread throughout the world. On March 11, 2020, the World Health Organization characterized the spread of COVID-19 as a "pandemic." The significant reach of COVID-19 resulted in a widespread public health issue that affected the economies worldwide, and adversely affected our business and our customer base. We experienced an immediate decrease in demand for our line of SANDD mini needle incineration devices by school systems and first responders. Further, future demand for our newly released SANDD Pro was delayed until hospitals, clinics, and physicians could resume normal operations. But, as a result of the pandemic, we were able to immediately pivot our sales efforts and expanded our line of medical device sales efforts to include personal protective equipment ("PPE"). We also capitalized on these business interruptions to modify and broaden our engineering re-design objectives of the SANDD Pro to improve the immediate capability of the SANDD Pro to incinerate 18-gauge needles, a necessity to address the incineration needs of hospitals and clinics.
"In November 2020, we decided to return our primary business focus to our main product line – SANDD needle incineration devices. While we will continue to offer for sale certain PPE products, we plan to significantly reduce our PPE inventories during the three-month period ending December 31, 2020. In some cases, this plan may result in sales at prices less than our original inventory cost, but we believe returning our focus to our original business model is the correct long-term course of action."